A Study of Galcanezumab in Participants With Chronic Cluster Headache

The main purpose of this study is to evaluate the efficacy of the study drug known as LY2951742 in participants with chronic cluster headache.

Trial Summary

Age Range
18 - 65 years
Conditions the trial is for
Chronic Cluster Headache
What the trial is testing?
Galcanezumab
Could I receive a Placebo?
Yes
Enrollment Goal
240
Trial Dates
Jun 18, 2015 - Aug 14, 2019
How long will I be in the trial?
Your participation will include scheduled office visits throughout the study period.
Trial Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.